BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  bluebird bio Appoints Alison Finger as Chief Commercial Officer

  In this role, Alison will be responsible for shaping and delivering an integrated global commercial strategy to make bluebird’s gene therapies broadly accessible to patients.

  February 14, 2018

   · 

  5 min read
• 

  FDA

  FDA Clears Glooko’s Long-Acting Insulin Titration System

  The Mobile Insulin Dosing System has been cleared by the FDA for the titration of long-acting insulin for people with type 2 diabetes.

  February 14, 2018

   · 

  4 min read
• Biotech Bay

  Simplify Medical Completes Enrollment in IDE Trial Studying Simplify Disc in One Level of Spine for Cervical Disc Replacement

  Simplify Medical today announced completion of enrollment in its U.S. IDE trial studying the Simplify Disc used for one-level cervical implantation of the device between C3 to C7 compared with a historical control group.

  February 14, 2018

   · 

  3 min read
• Drug Development

  The New England Journal of Medicine Publishes Biogen’s SPINRAZA (nusinersen) Phase III Study Results in Individuals with Later-Onset Spinal Muscular Atrophy

  Data from the other endpoints analyzed, including attainment of new motor milestones and upper limb motor function, were consistently in favor of individuals who received treatment and were considered clinically significant.

  February 14, 2018

   · 

  15 min read
• Business

  Five Prime Therapeutics to Announce Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on February 27

  The live audio webcast may be accessed through the “Events & Presentations” page in the “Investors” section of the company’s website.

  February 14, 2018

   · 

  1 min read
• Business

  Recipharm Appoints President Development Services to Drive End to End Offering

  Contract development and manufacturing organisation Recipharm has appointed Bernard Pluta to lead its new global development organisation.

  February 14, 2018

   · 

  3 min read
• Business

  Adamas to Announce Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on February 22, 2018

  The management team will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the financial results and provide a corporate update.

  February 14, 2018

   · 

  1 min read
• Drug Development

  Incysus Presents Positive Data on Drug-Resistant Immunotherapy for Glioblastoma at AACR CNS Immunotherapy Conference

  Dr. Lamb, presented new data on the Company’s adoptive cell therapy program for glioblastoma.

  February 14, 2018

   · 

  3 min read
• Drug Development

  Nohla Therapeutics Initiates Global LAUNCH Phase II Trial of NLA101 in Patients With AML

  The trial will evaluate Nohla’s lead product candidate, NLA101, in adult patients with AML who are at risk for myelosuppression after receiving high-dose chemotherapy.

  February 14, 2018

   · 

  3 min read
• Business

  Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2018

  The news release will include summary financial information for the company’s third quarter of fiscal year 2018, which ended on Friday, January 26, 2018.

  February 14, 2018

   · 

  1 min read